Successful treatment of lichen planus with low-molecular-weight heparin: A case series of seven patients Article

Pacheco, H, Kerdel, F. (2001). Successful treatment of lichen planus with low-molecular-weight heparin: A case series of seven patients . JOURNAL OF DERMATOLOGICAL TREATMENT, 12(2), 123-126. 10.1080/095466301317085444

cited authors

  • Pacheco, H; Kerdel, F

abstract

  • BACKGROUND: Lichen planus (LP) is characterized by features of a cell-mediated attack on the epidermis by activated T lymphocytes. CD4+ lymphocytes have been shown to produce endoglycosidase (heparanase), which allows them to penetrate into the subendothelial basal lamina. Low-molecular-weight heparin (enoxaparin) has been shown to inhibit expression of heparanase. METHODS: Seven patients with LP were treated with enoxaparin. RESULTS: Five experienced a marked improvement with no side effects. CONCLUSION: Enoxaparin may be an effective treatment for patients with lichen planus.

publication date

  • November 9, 2001

published in

Digital Object Identifier (DOI)

start page

  • 123

end page

  • 126

volume

  • 12

issue

  • 2